Endogenous reactive oxygen species burst induced and spatiotemporally controlled multiple drug release by traceable nanoparticles for enhancing antitumor efficacy
- 4 June 2021
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 9 (14) , 4968-4983
Abstract
Reactive oxygen species (ROS) are not only used as a therapeutic reagent in chemodynamic therapy (CDT), to stimulate the release of antineoplastic drugs, they can also be used to achieve a combined effect of CDT and chemotherapy to enhance anticancer effects. Herein, we synthesized a pH-responsive prodrug (PEG2k-NH-N-DOX), ROS-responsive prodrug (PEG2k-S-S-CPT-ROS), organic CDT agents (TPP-PEG2k-LND, TPP-PEG2k-TOS), and T1-enhanced magnetic resonance imaging contrast agents (Gd-DTPA-N16-16), and used them to encapsulate combrestatinA4 (CA4) to prepare traceable pH/ROS dual-responsive multifunctional nanoparticles (TLDCAG NPs) with endogenous ROS burst and spatiotemporally controlled multiple drug release ability. Firstly, TLDCAG NPs were accumulated in the tumor cell microenvironment via an enhanced permeability and retention (EPR) effect. Secondly, CA4 was released and specifically destroyed angiogenesis to facilitate the interaction between the tumor and the remaining TLDCG NPs. After accumulating in tumor cells, the TLDCG NPs could be destroyed under acidic conditions to quickly release doxorubicin (DOX), TPP-PEG2k-LND, and TPP-PEG2k-TOS. Thirdly, TPP-PEG2k-LND and TPP-PEG2k-TOS quickly targeted mitochondria, induced endogenous ROS bursts, reduced the mitochondrial membrane potential, and induced tumor cell apoptosis. Endogenous ROS can not only be used as a therapeutic reagent for CDT, but also can cut off the thioketal bond in PEG2k-S-S-CPT-ROS and release camptothecin (CPT). Finally, TLDCAG NPs were traced by magnetic resonance imaging (MRI). Furthermore, in vitro and vivo results indicate that the TLDCAG NPs have vigorous antitumor activity and negligible systemic toxicity. Therefore, the TLDCAG NPs provide an efficient strategy for enhancing antitumor efficacy.Keywords
Funding Information
- National Natural Science Foundation of China (22007009)
- Fundamental Research Funds for the Central Universities (DUT19GJ203)
- China Postdoctoral Science Foundation (2020M670743)
This publication has 44 references indexed in Scilit:
- Biodegradable Nanoscale Coordination Polymers for Targeted Tumor Combination Therapy with Oxidative Stress AmplificationAdvanced Functional Materials, 2020
- Platelet membrane biomimetic bufalin-loaded hollow MnO2 nanoparticles for MRI-guided chemo-chemodynamic combined therapy of cancerChemical Engineering Journal, 2020
- Mitochondrion-targeted selenium nanoparticles enhance reactive oxygen species-mediated cell deathNanoscale, 2019
- Hypoxia-activated NIR photosensitizer anchoring in the mitochondria for photodynamic therapyChemical Science, 2019
- Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapyNature Communications, 2019
- A mitochondria-targeted nanoradiosensitizer activating reactive oxygen species burst for enhanced radiation therapyChemical Science, 2018
- Glycyrrhetinic Acid Functionalized Graphene Oxide for Mitochondria Targeting and Cancer Treatment In VivoSmall, 2017
- A simple mitochondrial targeting AIEgen for image-guided two-photon excited photodynamic therapyJournal of Materials Chemistry B, 2017
- Polymer Prodrug-Based Nanoreactors Activated by Tumor Acidity for Orchestrated Oxidation/ChemotherapyNano Letters, 2017
- Mitochondria, Oxidants, and AgingCell, 2005